Published By: Syndicate Market Research
SMR: Noninvasive Prenatal Testing Market size and Key Trends
in terms of volume and value 2020
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach,
Florida 33442, USA
Tel: +1-386-310-3803
Toll Free: 1-855-465-4651
www.marketresearchstore.com
sales@marketresearchstore.com
Noninvasive Prenatal Testing Market
Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal diagnosis (NIPD). Non-invasive prenatal testing
(NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as trisomy 21
(Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) or a sex chromosome irregularity, such
as Turner syndrome. The testing can also be used to determine a baby's sex and rhesus (Rh) blood type. The Non-Invasive
Prenatal Test (NIPT) is a DNA test on maternal blood to screen for the fetal aneuploidies (chromosomes 21, 18, 13) during
pregnancy. Now, noninvasive prenatal testing is only available for women who have certain risk issue. Non-invasive prenatal
testing (NIPT) offers harmony, verifi, Panorama, informaSeq, VisibiliT, PrenaTest, BambniTest and other test.
The NIPT market is growing, due to rising healthcare expenditure. The common maternal age is rising in high income countries, owing
to varying pattern of employment, education and marriage and growing price of raising a child. The increase in common maternal age
is resulting in the development of the global NIPT market. The exponential growth of the NIPT market is supported by factors such as
high birth rate with Down syndrome, no risk of miscarriage with NIPT, and shifting trend toward child bearing at advanced maternal
age.
Get sample Reports: http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=63016
The report includes detailed competitive landscape of the global Non-Invasive Prenatal Test market and an analysis of Porter’s five
forces...